Virtual Exercise Program to Reduce Cancer Related Fatigue

October 16, 2023 updated by: University of Colorado, Denver

Feasibility and Effectiveness of an Innovative Exercise Program to Reduce Fatigue in Rural Cancer Survivors

The objective of this investigation is to establish the feasibility and initial effectiveness of a novel exercise program for rural cancer survivors in Colorado suffering from cancer related fatigue. Participation in an exercise program has regularly been shown to reduce fatigue in cancer survivors, though in-person, supervised participation has a greater effect on fatigue than home-based programs with no supervision. Access to these supervised programs are limited in rural areas, restricting the ability of rural cancer survivors to experience the fatigue-reducing benefits of exercise. The proposed program will use information on improvements in fatigue from participants in the BfitBwell Cancer Exercise Program to monitor improvements in fatigue in rural cancer survivors performing a home exercise program and trigger a telehealth session with a cancer exercise specialist to adapt the exercise prescription when improvements are less than expected. The BfitBwell Program is an established exercise program at the Anschutz Health and Wellness Center which has worked with over 600 cancer survivors and is highly effective at reducing cancer related fatigue. The goal of the program is to replicate the effects of a successful supervised exercise program in rural cancer survivors who do not have access to this type of program. This investigation will recruit 20 rural cancer survivors experiencing fatigue and assess their ability to participate in the program, as well as how well the program improves their fatigue. Interviews will be conducted with participants after the program to determine how future versions of the program could be improved. The investigators anticipate that this program will be feasible and effective, providing preliminary data to pursue a large-scale clinical trial of the program following this project's completion.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

The proposed exercise program utilizes a novel reference chart system to monitor cancer-related fatigue (CRF) and trigger necessary interventions. This reference chart has been developed from CRF data collected in 173 cancer survivors participating in the BfitBwell Program, a highly effective supervised exercise program pioneered at the University of Colorado. The reference chart estimates the continuous trajectory of fatigue improvement during the three-month program. The focus of this study is to extend the benefits of an effective, supervised exercise program to rural Coloradoans via a home exercise program supported by CRF monitoring and symptom-triggered telehealth sessions. Deviations from estimated improvements in CRF will trigger telehealth sessions with a cancer exercise specialist (CES) to adapt the exercise prescription, in real time, as in a supervised program. The intent is to replicate the effects of a supervised exercise program in cancer survivors in rural areas without access to such programs. The feasibility, effectiveness, and design of the program will be assessed with two specific aims.

Aim 1: Determine the feasibility and preliminary effectiveness of the proposed exercise program.

Objective 1a: Assess the enrollment rate of patients able and willing to participate in the program and the adherence of patients enrolled in the program to their prescribed exercise, CRF monitoring, and telehealth session participation.

Objective 1b: Assess the effect of the proposed program on CRF improvements in enrolled participants and compare this effect to that of the supervised BfitBwell exercise program.

Exploratory Objective 1: Assess the feasibility of the semi-continuous remote monitoring of fatigue (ecological momentary assessment) to better tailor the program to more acute changes in CRF.

Aim 2: Assess participant perspectives of barriers and facilitators to participation in the prescribed exercise and CRF monitoring.

Objective 2: Gather qualitative data on barriers and facilitators to participation from all participants enrolling in the program using semi-structured interviews.

This is an innovative program, being the first exercise intervention to implement real time adaptations for rural patients, with decisions anchored against a novel symptom monitoring system. Qualitative data will be collected to improve the next iteration of the program and to inform a future, large-scale clinical trial of program implementation in rural populations. The long-term goal is to develop a feasible and effective exercise program for rural cancer survivors which replicates the benefits of supervised exercise programs to which access may be restricted in rural settings.

This is a prospective, single-arm pilot intervention trial. It will collect objective data on the feasibility and effectiveness of the intervention, as well as qualitative data to inform how the intervention could be improved in future iterations. The exploratory aim will collect data on "in-the-moment" fatigue that could also inform novel future versions of the intervention.

This investigation will recruit adult cancer survivors treated at the University of Colorado Cancer Center (aged 18 years and over) who live in rural Colorado, have completed cancer treatment, and report moderate-to-severe CRF (> 3 on a 0-10 scale, per NCCN definition). Cancer type will be limited to the three types with the highest anticipated new cases in Colorado in 2020: breast, prostate, and lung. Only survivors who have completed medical treatment (chemotherapy and/or radiation), with curative intent, within the past 12 months, and have no additional treatment planned for the next four months, will be recruited. Rural participants will be defined as those who have greater than a 1-hour commute to the major front range cities (Denver, Fort Collins, and Colorado Springs). Participants must have home internet access and smartphones to allow participation in telehealth sessions and remote monitoring of exercise participation and fatigue. Participants with medical conditions that would impact the safety of, or participation in, an exercise program will be excluded. Twenty participants will be recruited in one year, with the goal of retaining at least 15 through the final assessment.

Participants will complete assessments (baseline and final) and exercise sessions virtually. The primary outcome measure will be the Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue) scale. Other assessment items will include measures of physical fitness and function. CRF will be assessed by questionnaires every two weeks, and semi-continuously with a smartphone application. The exercise program is 12 weeks long, and includes 2 mandatory virtual exercise sessions, and up to 5 triggered virtual exercise sessions. Participants will be mailed equipment to complete the study upon enrollment.

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Colorado
      • Aurora, Colorado, United States, 80045
        • Anschutz Health and Wellness

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult (>= 18 years) cancer survivor treated at the University of Colorado Cancer Center

    o A maximum age of 80 will be set as virtual exercise may become unsafe as individuals get older.

  • A primary cancer diagnosis of breast, prostate, or lung cancer
  • Current report of moderate-to-severe fatigue (> 3 on a 0-10 scale, per NCCN definition30)
  • Live in rural Colorado (> 1-hour commute to major front range city [Denver, Fort Collins, and Colorado Springs])
  • Completed medical cancer treatment (chemotherapy and/or radiation) with curative intent within past 12 months.

    o No additional treatment planned for next 4 months

  • High-speed home internet and smartphone

Exclusion Criteria:

  • Medical conditions that would impact the safety of, or participation in, an exercise program. This includes:

    • Orthopedic conditions such as advanced osteoarthritis, mobility-limiting amputations or chronic injuries, or mobility-limiting acute orthopedic injuries
    • Advanced rheumatoid arthritis
    • Widespread chronic pain conditions such as fibromyalgia
    • Pulmonary conditions such as chronic obstructive pulmonary disease, emphysema, interstitial lung disease, use of supplemental oxygen
    • Known cardiovascular disease, uncontrolled hypertension, or new cardiac event within the past 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Virtual exercise program
This arm will receive the virtual exercise program.
12 week exercise prescription targeting 3 days of at least 30 min of aerobic exercise and 2 days of resistance exercise per week. Adapted to individual abilities, goals, and needs. Exercise intensity targets a 6-7 out of 10 on a 0-10 rate of perceived exertion scale.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue) at 12 weeks
Time Frame: Baseline (week 0), 12 weeks
13-item instrument widely used to assess cancer related fatigue. Score range: 0-52. Lower scores indicate more fatigue.
Baseline (week 0), 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Steps per day
Time Frame: Baseline (week 0), 12 weeks
Average steps per day over a 7 day period, assessed with commercial fitness tracker
Baseline (week 0), 12 weeks
Changes in Average sleep time
Time Frame: Baseline (week 0), 12 weeks
Average sleep time per day over a 7 day period, assessed with commercial fitness tracker
Baseline (week 0), 12 weeks
Changes in Single limb stance
Time Frame: Baseline (week 0), 12 weeks
Time participant can stand on one leg, up to 30 s
Baseline (week 0), 12 weeks
Changes in Gait speed
Time Frame: Baseline (week 0), 12 weeks
Gait speed over a 4 m distance, in m/s
Baseline (week 0), 12 weeks
Changes in Timed up and go
Time Frame: Baseline (week 0), 12 weeks
Time (in s) to rise from a chair, walk 3 m, turn around, walk back to chair, and sit down
Baseline (week 0), 12 weeks
Changes in 30 s Sit-to-Stand
Time Frame: Baseline (week 0), 12 weeks
Number of times one can stand and sit from a chair in 30 s
Baseline (week 0), 12 weeks
Changes Tecumseh Step Test
Time Frame: Baseline (week 0), 12 weeks
Participants steps on and off an 8" step at a rate of 24 steps/min for 3 min. Heart rate is recorded at 30 s and 1 min after completion.
Baseline (week 0), 12 weeks
Changes in Functional Assessment of Cancer Therapy-General form (FACT-G) at 12 weeks
Time Frame: Baseline (week 0), 12 weeks
Common questionnaire assessing health related quality of life in cancer survivors, range 0-108, higher scores indicate better quality of life
Baseline (week 0), 12 weeks
Changes in Functional Assessment of Cancer Therapy-General form (FACT-G) at 6 month
Time Frame: Baseline (week 0), 6 months
Common questionnaire assessing health related quality of life in cancer survivors, range 0-108, higher scores indicate better quality of life
Baseline (week 0), 6 months
Changes in Functional Assessment of Cancer Therapy-General form (FACT-G) at 9 months
Time Frame: Baseline (week 0), 9 months
Common questionnaire assessing health related quality of life in cancer survivors, range 0-108, higher scores indicate better quality of life
Baseline (week 0), 9 months
Changes in Functional Assessment of Cancer Therapy-General form (FACT-G) at 15 months
Time Frame: Baseline (week 0), 15 months
Common questionnaire assessing health related quality of life in cancer survivors, range 0-108, higher scores indicate better quality of life
Baseline (week 0), 15 months
Changes in Multidimensional Fatigue Inventory (MFI) at 12 weeks
Time Frame: Baseline (week 0), 12 weeks
Questionnaire with multiple subscales of fatigue identified. Score range: 0-100, higher scores indicate increased fatigue
Baseline (week 0), 12 weeks
Changes in Multidimensional Fatigue Inventory (MFI) at 6 months
Time Frame: Baseline (week 0), 6 months
Questionnaire with multiple subscales of fatigue identified. Score range: 0-100, higher scores indicate increased fatigue
Baseline (week 0), 6 months
Changes in Multidimensional Fatigue Inventory (MFI) at 9 months
Time Frame: Baseline (week 0), 9 months
Questionnaire with multiple subscales of fatigue identified. Score range: 0-100, higher scores indicate increased fatigue
Baseline (week 0), 9 months
Changes in Multidimensional Fatigue Inventory (MFI) at 15 months
Time Frame: Baseline (week 0), 15 months
Questionnaire with multiple subscales of fatigue identified. Score range: 0-100, higher scores indicate increased fatigue
Baseline (week 0), 15 months
Changes in Hospital Anxiety and Depression Scale (HADS) at 12 weeks
Time Frame: Baseline (week 0), 12 weeks
Questionnaire to assess anxiety and depression in populations with medical conditions. Score range: 0-42, higher scores indicate presence of anxiety and depression
Baseline (week 0), 12 weeks
Changes in Hospital Anxiety and Depression Scale (HADS) at 6 months
Time Frame: Baseline (week 0), 6 months
Questionnaire to assess anxiety and depression in populations with medical conditions. Score range: 0-42, higher scores indicate presence of anxiety and depression
Baseline (week 0), 6 months
Changes in Hospital Anxiety and Depression Scale (HADS) at 9 months
Time Frame: Baseline (week 0), 9 months
Questionnaire to assess anxiety and depression in populations with medical conditions. Score range: 0-42, higher scores indicate presence of anxiety and depression
Baseline (week 0), 9 months
Changes in Hospital Anxiety and Depression Scale (HADS) at 15 months
Time Frame: Baseline (week 0), 15 months
Questionnaire to assess anxiety and depression in populations with medical conditions. Score range: 0-42, higher scores indicate presence of anxiety and depression
Baseline (week 0), 15 months
Change in Godin Leisure-Time Physical Activity Questionnaire (GLTPAQ) at 12 weeks
Time Frame: Baseline (week 0), 12 weeks
Self-report of time spent in light, moderate, and vigorous physical activity in minutes.
Baseline (week 0), 12 weeks
Change in Godin Leisure-Time Physical Activity Questionnaire (GLTPAQ) at 6 months
Time Frame: Baseline (week 0), 6 months
Self-report of time spent in light, moderate, and vigorous physical activity in minutes.
Baseline (week 0), 6 months
Change in Godin Leisure-Time Physical Activity Questionnaire (GLTPAQ) at 9 months
Time Frame: Baseline (week 0), 9 months
Self-report of time spent in light, moderate, and vigorous physical activity in minutes.
Baseline (week 0), 9 months
Change in Godin Leisure-Time Physical Activity Questionnaire (GLTPAQ) at 15 months
Time Frame: Baseline (week 0), 15 months
Self-report of time spent in light, moderate, and vigorous physical activity in minutes.
Baseline (week 0), 15 months
Change in Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue) at 6 months
Time Frame: Baseline (week 0), 6 months
13-item instrument widely used to assess cancer related fatigue. Score range: 0-52. Lower scores indicate more fatigue.
Baseline (week 0), 6 months
Change in Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue) at 9 months
Time Frame: Baseline (week 0), 9 months
13-item instrument widely used to assess cancer related fatigue. Score range: 0-52. Lower scores indicate more fatigue.
Baseline (week 0), 9 months
Change in Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue) at 15 months
Time Frame: Baseline (week 0), 15 months
13-item instrument widely used to assess cancer related fatigue. Score range: 0-52. Lower scores indicate more fatigue.
Baseline (week 0), 15 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ecological momentary assessments of fatigue
Time Frame: Semi-continuous throughout program, up to 12 weeks
11 point fatigue intensity scale with higher scores indicating increased fatigue
Semi-continuous throughout program, up to 12 weeks
The Feeling Scale - Pre-exercise
Time Frame: Immediately before each exercise session
11 point scale of perceived affect during exercise, positive scores indicating positive affect, negative scores indicating negative affect
Immediately before each exercise session
The Feeling Scale - Post-exercise
Time Frame: Immediately after each exercise session
11 point scale of perceived affect during exercise, positive scores indicating positive affect, negative scores indicating negative affect
Immediately after each exercise session
Rate of perceived exertion
Time Frame: Immediately after every exercise session
11 point scale of perceived work/intensity during exercise. Higher scores indicate more intense workout.
Immediately after every exercise session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ryan J Marker, PT, PhD, University of Colorado, Denver

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 11, 2021

Primary Completion (Actual)

April 12, 2023

Study Completion (Estimated)

May 1, 2024

Study Registration Dates

First Submitted

August 6, 2020

First Submitted That Met QC Criteria

August 26, 2020

First Posted (Actual)

August 31, 2020

Study Record Updates

Last Update Posted (Actual)

October 17, 2023

Last Update Submitted That Met QC Criteria

October 16, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20-2015.cc

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Exercise

3
Subscribe